Statins improve endothelial dysfunction and decrease C-reactive protein (CRP), which reflects inflammatory processes, oxidative stress and oxidized LDL levels in atheroma, all of which are involved in HF and complicate its pathogenesis [8,9,10]. This evidence concerns the gene CRP and endothelial dysfunction.